Oncopig Cancer Model

Manufacturer
Sus Clinicals, Inc | University of Illinois Comparative Genomics Laboratory | Oak Hill Genetics LLC
Effective date
2025-10-13
Label type
INTENTIONAL ANIMAL GENOMIC ALTERATION LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 02:52:29

Label at a glance#

ProductOncopig Cancer Model
Active ingredientCre-inducible Neo-KRASG12D-TP53R167H rDNA construct in the ITPRID1 gene in cross-bred swine
Label structure1 sections

Label contents#

Full prescribing information#

Cre-inducible Neo-KRASG12D-TP53R167H rDNA construct in the ITPRID1 gene in cross-bred swine

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

This is an investigational animal that contains intentional genomic alterations. This animal and any products derived from it are for research purposes only and not for use in humans or as food/feed unless authorization has been granted by the US Food and Drug Administration.FDA package labelFDA package label FDA package labelFDA package label FDA package labelFDA package label FDA package labelFDA package label FDA package labelFDA package label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
86150-0001-1Oncopig Cancer Model1 [arb'U] in 1 NOT APPLICABLENOT APPLICABLE15

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
86150-000186150-0001-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
42023-05-11full-release2026-06-01 02:50:51

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.